Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. (Q44560164)
Jump to navigation
Jump to search
scientific article published in August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. |
scientific article published in August 2003 |
Statements
Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial (English)
Chunde Bao
Shunle Chen
Yueying Gu
Zhiying Lao
Liqing Ni
Qiang Yu
Jianhua Xu
Xiangpei Li
Jialing Liu
Lingyun Sun
Peigen He
Jiliang Ma
Shuyun Xu